Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vivasvan Vykunta"'
Autor:
Ruifeng Sun, Jaewoong Lee, Tim Wartewig, Mark E. Robinson, Alberto Bigogno, David Fonseca Arce, Abu-Sayeef Mirza, Andrew Takeda, Lars Klemm, Vivasvan Vykunta, Brian Shy, Alexander Marson, Markus Müschen
Publikováno v:
Blood. 140:5975-5976
Autor:
Jaewoong Lee, Kohei Kume, Mark E. Robinson, Ruifeng Sun, Ning Ma, Zhengshan Chen, Gang Xiao, Kadriye Nehir Cosgun, Lai N. Chan, Etienne Leveille, Lars Klemm, Vivasvan Vykunta, Brian Shy, Huimin Geng, Selina M. Luger, Mark R. Litzow, Alexander Marson, Elisabeth Paietta, Nagarajan Vaidehi, Eric Meffre, Markus Müschen
Publikováno v:
Blood. 140:1698-1699
Autor:
Jennifer R. Hamilton, Diana M. Lopez, Cindy R. Sandoval Espinoza, Alexander E. Dejanov, Michael G. Poirer, Vivasvan Vykunta, Rachel J. Lew, Enrique Lin-Shiao, Carlos E. Castro, Brian R. Shy, Alexander Marson, Mohammad Saffari Doost, Wolfgang Pfeifer, Jennifer A. Doudna, Evelyn Chen, Elizabeth C. Stahl
DNA nanostructures are a promising tool for delivery of a variety of molecular payloads to cells. DNA origami structures, where 1000’s of bases are folded into a compact nanostructure, present an attractive approach to package genes; however, effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de2d8888b97cc7c800b8ac0999c0148d
https://doi.org/10.1101/2021.11.08.467750
https://doi.org/10.1101/2021.11.08.467750
Autor:
Hong Li, Alvin Ha, Lumeng Ye, Franziska Blaeschke, Jonathan H. Esensten, Jeffrey L. Wolf, Alexis Talbot, Vivasvan Vykunta, Brian R. Shy, Alexander Marson, Yan Yi Chen, Justin Eyquem, Murad R. Mamedov, Thomas G. Martin, David N. Nguyen, Jing-Yi Chung, Shane Vedova, Theodore L. Roth
CRISPR-Cas9 offers unprecedented opportunities to modify genome sequences in primary human cells to study disease variants and reprogram cell functions for next-generation cellular therapies. CRISPR has several potential advantages over widely used r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7ee679f232feb5ee3451549af26a95c
https://doi.org/10.1101/2021.09.02.458799
https://doi.org/10.1101/2021.09.02.458799
Autor:
Jeremy F. Brooks, Kenta Hibiya, Corey Tan, Vivasvan Vykunta, Julie Zikherman, James L. Mueller, Ryosuke Hiwa
Publikováno v:
Cell reports, vol 36, iss 9
Cell reports
Cell reports
SUMMARY B cell clones compete for entry into and dominance within germinal centers (GCs), where the highest-affinity B cell receptors (BCRs) are selected. However, diverse and low-affinity B cells can enter and reside in GCs for extended periods. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ee4ae527552fa4c60ee1831be2931e1
https://escholarship.org/uc/item/3ts2z8zf
https://escholarship.org/uc/item/3ts2z8zf
Autor:
Kenta Hibiya, Jose Ramon Quiros Garcia, Ryosuke Hiwa, Corey Tan, Alexander Marson, Zhongmei Li, Mark Noviski, Cheryl S. Heyn, Vivasvan Vykunta, John Huizar, Jeremy F. Brooks, James L. Mueller, Julie Zikherman
Publikováno v:
Nature immunology, vol 21, iss 10
Antigen stimulation (signal 1) triggers B cell proliferation and primes B cells to recruit, engage and respond to T cell help (signal 2). Failure to receive signal 2 within a defined time window results in B cell apoptosis, yet the mechanisms that en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70668a96fbf4adf94b960ec5facb6acb
https://escholarship.org/uc/item/40v04025
https://escholarship.org/uc/item/40v04025
Publikováno v:
J Immunol
Journal of immunology (Baltimore, Md. : 1950), vol 203, iss 2
Journal of immunology (Baltimore, Md. : 1950), vol 203, iss 2
It has long been appreciated that highly autoreactive BCRs are actively removed from the developing B cell repertoire by Ag-dependent receptor editing and deletion. However, there is persistent debate about whether mild autoreactivity is simply toler